Phase 1/2 Clinical Study of VRDN-001, A Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients with Thyroid Eye Disease (TED)Mark Moster,Raymond Douglas,Kimberly Cockerham,Roger Turbin,Navdeep Nijhawan,Jade Schiffman,Shoaib Ugradar,Denis O'Shaughnessy,Rochelle Summerfelt,Angela She,Barrett KatzNEUROLOGY(2023)引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要